TGTX EPS Estimates
TG Therapeutics, Inc.
$56.00
+$1.63(+3.00%)
57
Overall
50
Value
60
Tech
63
Quality
Market Cap
$8.32B
Volume
1.81M
52W Range
$26.76 - $59.30
Target Price
$63.88
TGTX EPS estimates: the consensus estimate for TG Therapeutics, Inc.'s current fiscal year is $0.92 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TGTX EPS Estimates
- EPS estimate, current quarter
- $0.37
- EPS estimate, next quarter
- $0.38
- EPS estimate, current year
- $0.92
- EPS estimate, next year
- $2.65
- EPS growth, 3-year
- +60.35%
| Fiscal year | EPS |
|---|---|
| 2025 | $3.10 |
| 2024 | $0.16 |
| 2023 | $0.09 |
| 2022 | $-1.46 |
| 2021 | $-2.63 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TGTX | $56.00 | +3.0% | 1.81M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |